Cell-based cardiac pumps and tissue-engineered ventricles

Regenerative Medicine

Volumn 2, Issue 4, 2007, Pages 391-406

  Khait, L ^a   Birla, Ravi K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Artificial heart; Biomaterials; Bioreactors; Cardiac patches; Cell transplantation; Heart muscle; Pressure; Tissue engineering; Ventricles

Indexed keywords

ALGINIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOMATERIAL; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIN; INOTROPIC AGENT; POLYGLYCOLIC ACID; VASODILATOR AGENT;

CARDIOVASCULAR DISEASE; CELL MATURATION; CELL VIABILITY; DRUG DELIVERY SYSTEM; ELECTROSTIMULATION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; IN VITRO STUDY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MORTALITY; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

HEART VENTRICLES; HUMANS; TISSUE ENGINEERING;

EID: 34548149465     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.2.4.391     Document Type: Review

References (96)

1. Langer R, Vacanti JP: Tissus engineering. Science 260(5110), 920-926 (1993).
2. Chapekar MS: Tissue engineering. challenges and opportunities. J. Biomed. Mater. Res 53(6), 617-620 (2000).
3. Lysght MJ, Reyes J: The growth of tissue engineering. TissuEng. 7(5), 485-493 (2001).
4. Fuchs JR, Nasseri BA, Vacanti JP: Tissue engineering a 21st century solution to surgical reconstruction. Ann. Thorac Surg 72(2), 577-591 (2001).
5. Nerem RM: Tissue engineering the hope, the hype, and the future. Tissue Eng. 12(5) 1143-1150 (2006).
6. Vacanti CA: History of tissue engineering and a glimpse into its future. Tissue Eng 12(5) 1137-1142 (2006).
7. Shieh SJ, Vacanti JP: State-of-the-art tissue engineering: from tissue engineering to organ building. Surgery 137(1), 1-7 (2005).
8. Lavik E, Langer R: Tissue engineering current state and perspectives Appl. Microbiol. Biotechnol. 65(1), 1-8 (2004).
9. Rosamond W, Flegal K, Friday G et al.: Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommitte. Circulation 115(5), 69-171 (2007).
10. Zipes DP, Braunwald E: Braunweld's Heart Disease a Textbook of Cardiovascular Medicine(7th Edition). Zipes DP, Libby P, Bonow R (Eds). WB Saunders, PA, USA (2005).
11. Miniati DN, Robbins RC: Heart transplantation: a thirty-year perspective. Annu. Rev. Med. 53, 189-205 (2002).
12. Goldstein S: Heart failure therapy at the turn of the century. Heart Fail. Rev. 6(1), 7-14 (2001).
13. Stevenson LW, Komos RL: Mechanical cardiac support (2000): current applications future trial design. J. Heart Lung Transplant. 20(1), 1-38 (2001)
14. Murry CE, Reinecke H, Pabon LM: Regeneraton gaps observationson stem cells and cardiac repair. J. Am. Cdl. Cardiol. 47(9) 1777-1785 (2006).
15. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair reflectionsat the 10-year point. Circulation 112(20), 3174-3183 (2005).
16. Laflamme MA, Murry CE Regenerating the heart. Nat. Biotechnol. 23(7), 845-856 (2005).
17. Murry CE, Whitney ML, Reinecke H: Muscle cell grafting for the treatment and prevention of heart failure. J. Card. Fail. 8(6 Suppl.), S532-S541 (2002).
18. Pittenger M F, Martin B.J: Mesenchymal stem calls and their potential as cardiac therapeutics Circ. Res 95(1), 9-20 (2004).
19. Rabkin E, Schoen FJ: Cardiovascular tissue engineering. Cardiovasc. Pathol. 11(6), 305-317 (2002).
20. Akins RE: Can tissue engineering mend broken hearts? Circ Res 90(2), 120-122 (2002).
21. Li RK, JaZQ, Weisel RD, MickleDA, Choi A, Yau TM: Survival and function of bioengineered cardiac grafts Circulation 100(19 Suppl.), 1163-1169 (1999).
22. Carrier RL, Papadaki M, Rupnick M et al. Cardiac tissue engineering cell seeding, cultivation parameters and tissue construct characterization. Biotechnol. Bioeng 64(5), 580-589 (1999).
23. Folliguet TA, Rucker-Martin C, Pavoine C et al.: Adult cardiac myocytes survive and remain excitable during long-term culture on syntheticsupports. J. Thorac Cardiovasc Surg 121(3), 510-519 (2001).
24. Shimizu T, Yamato M, Kikuchi A, Okano T: Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature responsiveculture dishes augmentsthe pulsatileamplitude, TissueEng 7(2), 141-151 (2001).
25. Papadaki M, Bursac N, Langer R Merck J, Vunjak-Novakovic G, Freed LE: Tissue engineering of functional cardiac muscle molecular, structural, and electrophysiological studies Am. J. Physiol. Heart Circ Physiol. 280(1), H168-H178 (2001).
26. Bursac N, Papadaki M, Cohen RJ et al.: Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies Am. J. Physiol. 277(2 Pt 2), H433-H444 (1999).
27. Shimizu T, Yamato M, Akutsu T et al.: Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocte sheets. J. Biomed. Mater. Res 60(1), 110-117 (2002).
28. Zimmermann WH, Schneiderbanger K, Schubert P et al.: Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90(2), 223-230(2002).
29. Shimizu T, Yamamoto M, Isoi Y et al.: Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90(3), E40 (2002).
30. Akins RE, Boyce RA, Madonna ML et al.: Cardiac organogenesisin vitro reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. TissueEng 5(2), 103-118 (1999).
31. Leor J, Aboulafia-Etzion S, Dar A et al.: Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102(19 Suppl. 3), 11156-11161 (2000).
32. Li RK, Yau TM, Weisel RD et al.: Construction of a bioengineered cardiac graft. J. Thorac Cardiovasc Surg 119(2), 368-375 (2000).
33. Zimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail. Rev. 8(3), 259-269 (2003).
34. Eschenhagen T, Didie M, Munzel F, Schubert P, Schneiderbanger K, Zimmermann WH: 3D engineered heart tissue for replacement therapy. Basic Res Cardiol. 97(Suppl. 1), I146-I152 (2002).
35. Zimmermann WH, Didie M, Wasmeier GH et al.: Cardiac grafting of engineered heart tissue in syngenic rats Circulation 106(12 Suppl. 1), I151-I157 (2002).
36. Eschenhagen T, Didie M, Heubach J, Ravens U, Zimmermann WH: Cardiac tissue engineering. Transpl. Immunol. 9(2-4), 315-321 (2002).
37. Kofidis T, Akhyari P, Boublik J et al.: In vitro engineering of heart muscle artificial myocardial tissue. J. Thorac Cardiovasc Surg 124(1), 63-69 (2002).
38. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T: Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng 68(1), 106-114 (2000).
39. Eschenhagen T, Fink C, Rammers U et al.: Three-dimensional reconstitution of embyonic cardiomyocytes in a collagen matrix: a new heart muscle model sytstem. FASEB J 11(8), 683-694 (1997).
40. Shimizu T, Yamato M, Kikuchi A, Okano T: Cell sheet engineering for myocardial tissue reconstruction. Biomaterials24(13), 2309-2316 (2003).
41. Papadaki M: Cardiac muscle tissue engineering. IEEE Eng Med. Biol. Mag 22(3), 153-154 (2003).
42. Dar A, Shachar M, Leor J, Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol. Bioeng. 80(3), 305-312 (2002).
43. Kofidis T, Akhyari P, Wachsmann B et al.: A novel bioartificial myocardial tissue and its prospective use in cardiac surgery. Eur. J. Cardiothorac. Surg 22(2), 238-243 (2002).
44. van Luyn MJ, Tio, RA, van Seijen XJ et al.: Candiac tissue engineering characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures. Biomaterials23(24), 4793-4801 (2002).
45. Radsic M, Euloth M, Yang E, Langer R, Freed LE, Vunjak-Novakovio G: High-density seeding of myocyte colisfer cardiac tissue engineering. Biotechnol. Bloeng 82(4), 403-414 (2003).
46. Huang YC, Khait L, Brila RK, Contractile three-dimensional bioengineered heart muscle for myocardiel regeneration. J. Biomed. Mater. Res A 80, 719-731 (2007).
47. Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT: Custom design of the cardiac microenvironment with biomaterials. Circ Res 97(1), 8-15 (2005).
48. Rosso F, Marino G, Giordano A, Barberisi M, Permeggiani D, Barberisi A: Smart materials as scaffolds for tissue engineering. J. Cell. Physiol. 203(3), 465-470 (2005).
49. Zisch AH, Lutolf MP, Ehrbar M et al.: Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth metrices for vascularized tissue growth. FASEB J. 17(15), 2260-2262 (2003).
50. Ehrbar M, Djonov VG, Schnell C et al.: Cell-demanded liberation of VEGF121 from fibrin implantsinduceslocal and controlled blood vessel growth. Circ Res. 94(8), 1124-1132 (2004).
51. Seliktar D, Zisch AH, Lutolf MP, Wrana L, Hubbell JA: MMP-2 sensitive VEGF-bearing bioactive hydrogels for promotion of vascular healing. J. Biomed. Mater. Res A 68(4), 704-716 (2004).
52. Kusonwiriyawong C, van de WP, Hubbell JA, Merkle HP, Walter E: Evaluation of pH-dependent membrane-disruptive properties of poly(acyrlic acid) derived polymers. Eur. J. Pharm. Biopharm. 56(2), 237-246 (2003).
53. Napoli A, Valentini M, Tirelli N, Muller M, Hubbell JA: Oxidation-responsive polymeric vesicle. Nat. Mater. 3(3), 183-189 (2004).
54. Napoli A, Boerakker MJ, Tirelli N, Nolte RJ, Sommerdjk NA, Hubbell JA: Glucose oxidase based self-destructing polymeric vesicles. Langmuir 20(9), 3487-3491 (2004).
55. Lutolf MP, Hubbell JA: Synthetic biomaterialsasintructiveextracellular microenvironments for morphogenesisin tissueengineering. Nat. Biotechnol. 23(1), 47-55 (2005).
56. Ratner BD, Bryant SJ: Biomaterials where we have been and where we are going. Annu. Rev. Biomed. Eng 6,41-75 (2004).
57. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA: A completely biological tissue-engineered human blood vessel. FASEB J. 12(1), 47-56 (1998).
58. Niklason LE, Gao J, Abbot WM et al.: Functional arteries grown in vitro. Science 248(5413), 489-493 (1999).
59. Yeeger A, Callow AD: New graft materials and current approaches to an acceptable small diameter vascular graft. ASAIO Trans 34(2), 88-94 (1988).
60. Yow KH, Ingram J, Korossis SA, Ingham E, Homer-Vanniasinkam S. Tissue engineering of vascular conduits Br. J. Surg. 93(6), 652-661 (2006).
61. Sodian R, Sperling JS, Martin DP et al.: Fabrication of atrileeflet heart valve scaffold from a polyhydroxylkanoate biopolyester for use in tissue engineering. Tissue Eng. 6(2), 183-188 (2000).
62. Sodian R, Hoerstrup SP, Sperling JS et al.: Evaluation of biodegradable, three-dimensional matrioes for tissue engineering of heart valves ASAIO J. 46(1), 107-110 (2000).
63. Steinhoff G, Stock U, Karim N et al.: Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits in vivo restoration of valve tissue. Circulation 102(19 Suppl. 3), 11150-11155 (2000).
64. Hollister SJ: Porous scaffold design for tissue engineering. Nat. Mater. 4(7), 518-524. (2005).
65. Birla RK, Borschel GH, Dennis RG, Brown DL: Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 11(5-6), 803-813(2005).
66. Beer K, Birla R, Boluyt MO, Borshel GH, Arruda EM, Dennis RG: Self-organization of rat cardiac cell into contractile 3D cardiac tissue FASEB J. 19(2), 275-277 (2005).
67. Taylor DA, Silvestry SC, Bishop SP et al.: Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. Proc. Assoc. Am. Physicians 109(3), 245-253 (1997).
68. Chiu RC, Zibaitis A, Kao RL: Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann. Thorac. Surg 60(1), 12-18 (1995).
69. Zibaitis A, Greentree D, MaF, Marelli D, Duong M, Chiu RC: Myocardial regeration with satellite cell immplantation. Transplant. Proc. 26(6) 3294 (1994).
70. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD: Skeletal myoblast transplantation for repair of myocardial necrisis J. Clin. Invest. 98(11), 2512-2523 (1996).
71. Robinson SW, Cho FW, Levitsky HI et al.: Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. Cell Transplant. 5(1), 77-91 (1996).
72. Atkins BZ, Lewis CW, Kraus WE, Hutcheson KA, Glower DD, Taylor DA: Intracardiac transplantation of skeletal myoblasts yields two population of striated cells in situ. Ann. Thorac Surg. 67(1), 124-129 (1999).
73. Dawn B, Bolli R: Bone marrow cells for cardiac regeneration: the quest for the protagonist continues Cardiovasc Res 65(2), 293-295 (2005).
74. Vanelli P, Beltrami S, Cesana E et al.: Cardiac precursors in human bone marrow and cord blood: in vitro cell cardiogenesis Ital. Heart J. 5(5), 384-388 (2004).
75. Shim WS, Jang S, Wong P et al.: Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells Biochem. Biophys. Res Commun. 324(2), 481-488 (2004).
76. Hattan N, Kawaguchi H, Ando K et al.: Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc. Res 65(2), 334-344 (2005).
77. Fernandez-Aviles F, San Roman JA, Garcia-Frade J et al.: Experimental and clinical regerative capability of human bone marrow cells after myocardial infarction. Circ. Res 95(7), 742-748 (2004).
78. Khor E, Lim LY: Implatable applications of chitin and chitosan. Biomaterials24(13), 2339-2349 (2003).
79. Itoh S, Suzuki M, Yamaguchi I et al.: Development of a nerve scaffold using a tendon chitosan tube. Artif. Organs27(12), 1079-1088 (2003).
80. Suh JK, Matthew HW: Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials21(24), 2589-2598 (2000).
81. Madihally SV, Matthew HW: Porous chitosan scaffolds for tissue engineering. Biomaterials 20(12), 1133-1142 (1999).
82. Mi FL, Shyu SS, Wu YB, Lee ST, Shyong JY, Huang RN: Fabrication and characterization of a sponge-like asymmetic chitosan membrance as a wound dressing. Biomaterials 22(2), 165-173 (2001).
83. Sechriest VF, Miao YJ, Niyibizi C et al.: GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis J. Biomed. Mater. Res 49(4), 534-541 (2000).
84. Muzzarelli RA: Human enzymatic activities related to the therapeutic administratortion of chitin derivatives Cell. Mol. Life Sci. 53(2), 131-140 (1997).
85. Tomihata K, Ikada Y: In vitro and in vivo degradation of films of chitin and its deecetylated derivatives. Biomaterials 18(7), 567-575 (1997).
86. Lee KY, Ha WS, Park WH: Blood compatibility and biodegradability of partially N-acylated chitosan derivation. Biomaterials 16(16), 1211-1216 (1995).
87. VandeVord PJ, Mathew HW, DeSilva SP, Mayton L, Wu B, Wooley PH: Evaluatiom of the biocompatibility of a chitosen scaffold in mice, J. Biomed. Mater. Res 59(3), 585-590 (2002).
88. Onishi H, Machida Y: Biodegration and distribution of wate-soluble chitosen in mice. Biomaterials20(2), 175-182 (1999).
89. Ma J, Wang H, HeB, Chen J: A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosen bilayer material as a scaffold of human neofetal dermal fibroblsts. Biomaterials22(4), 331-336 (2001).
90. Zhang Y, Zhang M: Synthesis and characterization of macroporous chitosen/ calcium phosphate composite scaffolds for tissue engineering. J. Biomed. Mater. Res 55(3), 304-312 (2001).
91. Zhang Y, Zhang M: Three-dimensional macroporous calcium phosphate bioceramics with nested chitosan sponges for load-bearing bone implants. J. Biomed. Mater. Res 61(1), 1-8 (2002).
92. Zhang Y, Ni M, Zhang M, Ratner B: Calcium phosphate-chitosan composite scaffolds for bone tissue engineering. Tissue Eng 9(2), 337-345 (2003).
93. Chung TW, Yang J, Akaike T et al.: Preparation of alginate/ galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials23(14), 2827-2834 (2002).
94. Park IK, Yang J, Jeong H J et al.: Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment. Biomaterials24(13), 2331-2337 (2003).
95. Yang J, Chung TW, Nagaoka M, Goto M, Cho CS, Akaike T: Hepatocyte-specific porous polymer-scaffolds of alginate/galactosylated chitosan sponge for liver-tissue engineering. Biotechnol. Lett. 23(17), 1385-1389 (2001).
96. Cui W, Kim DH, Imamura M, Hyon SH, Inoue K: Tissue-engineered pancreatic islets culturing rat islets in the chitosan sponge. Cell Transplant. 10(4-5), 499-502 (2001).